Want to join the conversation?
$HSP General Update: Obtained U.S. FDA approval for launch of bivalirudin for injection, a generic version of The Medicines Company's Angiomax. Branded sales of Angiomax in 2014 in the United States were approximately $500MM.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.